STS/ACC TVT Registry Mitral Module

Launched by AMERICAN COLLEGE OF CARDIOLOGY · Sep 19, 2014

Keywords

ClinConnect Summary

The STS/ACC TVT Registry Mitral Module is a clinical trial focused on understanding how safe and effective a new procedure called transcatheter mitral valve repair (TMVR) is for treating mitral valve regurgitation, a condition where the heart's mitral valve doesn't close properly, causing blood to flow backward. This trial, developed by The Society of Thoracic Surgeons and the American College of Cardiology, aims to collect important information about patients' experiences and outcomes after undergoing this procedure.

Anyone over the age of one year may be eligible to participate, as long as they don’t have certain conditions that could complicate the procedure, like active infections of the heart valve or specific blood clots. Participants will receive the TMVR procedure and be monitored for their recovery and results. This research is crucial as it helps doctors understand how well this new treatment works in real-life situations, ultimately improving care for patients with mitral valve issues. If you or a loved one is considering this procedure, joining the trial could contribute to valuable insights that benefit future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients
• Exclusion Criteria:
• • Patients who cannot tolerate procedural anticoagulation or post procedural anti-platelet regimen
• • Active endocarditis of the mitral valve
• • Rheumatic mitral valve disease
• • Evidence of intracardiac, inferior vena cava (IVC) or femoral venous thrombus